Minimal residual disease status predicts outcomes in patients with follicular lymphoma treated with chemo-immunotherapy on the SWOG S0016 trial
Not available.
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2025-07-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/12159 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849427132591112192 |
|---|---|
| author | Alexey V. Danilov Hongli Li Mazyar Shadman Lisa Rimsza Ahmad Zebari Sonali M. Smith Michael LeBlanc Jonathan W. Friedberg Christopher Carlson Joo Y. Song |
| author_facet | Alexey V. Danilov Hongli Li Mazyar Shadman Lisa Rimsza Ahmad Zebari Sonali M. Smith Michael LeBlanc Jonathan W. Friedberg Christopher Carlson Joo Y. Song |
| author_sort | Alexey V. Danilov |
| collection | DOAJ |
| description |
Not available.
|
| format | Article |
| id | doaj-art-2ac246aba0c2477aa8a60a0843c5fce9 |
| institution | Kabale University |
| issn | 0390-6078 1592-8721 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Ferrata Storti Foundation |
| record_format | Article |
| series | Haematologica |
| spelling | doaj-art-2ac246aba0c2477aa8a60a0843c5fce92025-08-20T03:29:07ZengFerrata Storti FoundationHaematologica0390-60781592-87212025-07-01999110.3324/haematol.2025.288057Minimal residual disease status predicts outcomes in patients with follicular lymphoma treated with chemo-immunotherapy on the SWOG S0016 trialAlexey V. Danilov0Hongli Li1Mazyar Shadman2Lisa Rimsza3Ahmad Zebari4Sonali M. Smith5Michael LeBlanc6Jonathan W. Friedberg7Christopher Carlson8Joo Y. Song9City of Hope Comprehensive Cancer Center, DuarteSWOG Statistical and Data Management Center, Seattle, WA; Fred Hutchinson Cancer Center, Seattle, WAFred Hutchinson Cancer Center, Seattle, WAUniversity of Arizona, Tucson, AZFred Hutchinson Cancer Center, Seattle, WAUniversity of Chicago Comprehensive Cancer Center, Chicago, ILSWOG Statistical and Data Management Center, Seattle, WA; Fred Hutchinson Cancer Center, Seattle, WAUniversity of Rochester, RochesterFred Hutchinson Cancer Center, Seattle, WACity of Hope Comprehensive Cancer Center, Duarte Not available. https://haematologica.org/article/view/12159 |
| spellingShingle | Alexey V. Danilov Hongli Li Mazyar Shadman Lisa Rimsza Ahmad Zebari Sonali M. Smith Michael LeBlanc Jonathan W. Friedberg Christopher Carlson Joo Y. Song Minimal residual disease status predicts outcomes in patients with follicular lymphoma treated with chemo-immunotherapy on the SWOG S0016 trial Haematologica |
| title | Minimal residual disease status predicts outcomes in patients with follicular lymphoma treated with chemo-immunotherapy on the SWOG S0016 trial |
| title_full | Minimal residual disease status predicts outcomes in patients with follicular lymphoma treated with chemo-immunotherapy on the SWOG S0016 trial |
| title_fullStr | Minimal residual disease status predicts outcomes in patients with follicular lymphoma treated with chemo-immunotherapy on the SWOG S0016 trial |
| title_full_unstemmed | Minimal residual disease status predicts outcomes in patients with follicular lymphoma treated with chemo-immunotherapy on the SWOG S0016 trial |
| title_short | Minimal residual disease status predicts outcomes in patients with follicular lymphoma treated with chemo-immunotherapy on the SWOG S0016 trial |
| title_sort | minimal residual disease status predicts outcomes in patients with follicular lymphoma treated with chemo immunotherapy on the swog s0016 trial |
| url | https://haematologica.org/article/view/12159 |
| work_keys_str_mv | AT alexeyvdanilov minimalresidualdiseasestatuspredictsoutcomesinpatientswithfollicularlymphomatreatedwithchemoimmunotherapyontheswogs0016trial AT honglili minimalresidualdiseasestatuspredictsoutcomesinpatientswithfollicularlymphomatreatedwithchemoimmunotherapyontheswogs0016trial AT mazyarshadman minimalresidualdiseasestatuspredictsoutcomesinpatientswithfollicularlymphomatreatedwithchemoimmunotherapyontheswogs0016trial AT lisarimsza minimalresidualdiseasestatuspredictsoutcomesinpatientswithfollicularlymphomatreatedwithchemoimmunotherapyontheswogs0016trial AT ahmadzebari minimalresidualdiseasestatuspredictsoutcomesinpatientswithfollicularlymphomatreatedwithchemoimmunotherapyontheswogs0016trial AT sonalimsmith minimalresidualdiseasestatuspredictsoutcomesinpatientswithfollicularlymphomatreatedwithchemoimmunotherapyontheswogs0016trial AT michaelleblanc minimalresidualdiseasestatuspredictsoutcomesinpatientswithfollicularlymphomatreatedwithchemoimmunotherapyontheswogs0016trial AT jonathanwfriedberg minimalresidualdiseasestatuspredictsoutcomesinpatientswithfollicularlymphomatreatedwithchemoimmunotherapyontheswogs0016trial AT christophercarlson minimalresidualdiseasestatuspredictsoutcomesinpatientswithfollicularlymphomatreatedwithchemoimmunotherapyontheswogs0016trial AT jooysong minimalresidualdiseasestatuspredictsoutcomesinpatientswithfollicularlymphomatreatedwithchemoimmunotherapyontheswogs0016trial |